Centre confirms presence of JN.1 Covid subvariant

Saturday, 16 December 2023
The Centre confirms the presence of the JN.1 subvariant of Covid-19 in Kerala, the first case in India. JN.1 is closely related to the BA.2.86 variant, also known as Pirola, detected in the US and China. The patient from Thiruvananthapuram tested positive for JN.1 on December 8 and has since recovered. Kerala has seen a rising trend in Covid cases, with most cases being mild and patients recovering at home. A mock drill is being conducted in health facilities to assess preparedness measures.

👓 View full article

0 shares	Share Tweet Save Post Send

Video Credit: Wibbitz Top Stories - Published on December 19, 2023

News video: WHO Says Risk 'Low' From COVID Strain Deemed 'Variant of Interest'

WHO Says Risk 'Low' From COVID Strain Deemed 'Variant of Interest' 01:31

WHO Says Risk 'Low' , From COVID Strain Deemed , 'Variant of Interest'. 'The Independent' reports that the JN.1 variant of COVID-19 has been classified as a "variant of interest" by officials who added that it poses a minor threat to public health. On December 19, the World Health...

💡 newsR Knowledge: Other News Mentions

COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia Duration: 03:29Published on January 1, 1970